Receptors, Antigen, T-Cell
"Receptors, Antigen, T-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains.
Descriptor ID |
D011948
|
MeSH Number(s) |
D12.776.543.750.705.816.824
|
Concept/Terms |
Receptors, Antigen, T-Cell- Receptors, Antigen, T-Cell
- T-Cell Antigen Receptor
- Antigen Receptor, T-Cell
- Receptor, T-Cell Antigen
- T Cell Antigen Receptor
- T-Cell Receptors
- Receptors, T-Cell
- T Cell Receptors
- T-Cell Receptor
- Receptor, T-Cell
- T Cell Receptor
- Receptors, T-Cell Antigen
- Receptors, T Cell Antigen
- T-Cell Antigen Receptors
- Antigen Receptors, T-Cell
- Antigen Receptors, T Cell
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Antigen, T-Cell".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Antigen, T-Cell".
- Receptors, Antigen, T-Cell
- Complementarity Determining Regions
- Receptor-CD3 Complex, Antigen, T-Cell
- Receptors, Antigen, T-Cell, alpha-beta
- Receptors, Antigen, T-Cell, gamma-delta
This graph shows the total number of publications written about "Receptors, Antigen, T-Cell" by people in this website by year, and whether "Receptors, Antigen, T-Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 1 | 3 | 4 |
1994 | 0 | 5 | 5 |
1995 | 2 | 1 | 3 |
1996 | 2 | 3 | 5 |
1997 | 5 | 0 | 5 |
1998 | 4 | 4 | 8 |
1999 | 4 | 3 | 7 |
2000 | 0 | 5 | 5 |
2001 | 7 | 2 | 9 |
2002 | 3 | 3 | 6 |
2003 | 4 | 7 | 11 |
2004 | 5 | 6 | 11 |
2005 | 6 | 5 | 11 |
2006 | 5 | 4 | 9 |
2007 | 1 | 4 | 5 |
2008 | 3 | 3 | 6 |
2009 | 3 | 2 | 5 |
2010 | 4 | 2 | 6 |
2011 | 1 | 3 | 4 |
2012 | 7 | 2 | 9 |
2013 | 6 | 4 | 10 |
2014 | 6 | 3 | 9 |
2015 | 5 | 2 | 7 |
2016 | 7 | 7 | 14 |
2017 | 3 | 2 | 5 |
2018 | 6 | 4 | 10 |
2019 | 6 | 6 | 12 |
2020 | 4 | 1 | 5 |
2021 | 5 | 4 | 9 |
2022 | 1 | 11 | 12 |
2023 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Antigen, T-Cell" by people in Profiles.
-
Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results. Blood Adv. 2023 06 13; 7(11):2283-2286.
-
Linking Body Composition and Nutritional Status with CAR T-cell Efficacy. Cancer Immunol Res. 2023 06 02; 11(6):704.
-
Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia. Cell Death Dis. 2023 05 04; 14(5):305.
-
Predictive and Prognostic Implications of Circulating CX3CR1+ CD8+ T Cells in Non-Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy. Cancer Res Commun. 2023 03; 3(3):510-520.
-
Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy. Nature. 2023 03; 615(7953):697-704.
-
Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells. Sci Rep. 2022 12 29; 12(1):22539.
-
Non-viral precision T?cell receptor replacement for personalized cell therapy. Nature. 2023 03; 615(7953):687-696.
-
Clonal lineage tracing reveals mechanisms skewing CD8+ T cell fate decisions in chronic infection. J Exp Med. 2023 01 02; 220(1).
-
Longitudinal analysis reveals age-related changes in the T cell receptor repertoire of human T cell subsets. J Clin Invest. 2022 09 01; 132(17).
-
Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantation. J Allergy Clin Immunol. 2023 01; 151(1):260-271.